Farmaceutica Remedia (LTS:0M8I) Total Liabilities: lei274.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0M8I Farmaceutica Remedia SA LTS:0M8I
58 GF Score
Price lei0.25
GF Value lei0.23
! 8 Warning Signs
View Full Analysis

What is Farmaceutica Remedia Total Liabilities?

Farmaceutica Remedia LTS:0M8I 58 Total Liabilities is lei274.3 Mil as of Mar. 2026. GuruFocus rates LTS:0M8I with a GF Score™ of 58/100 and a GF Value™ of lei0.23. The stock has 8 warning signs investors should review.

Farmaceutica Remedia's Total Liabilities for the quarter that ended in Mar. 2026 was lei274.3 Mil.

Farmaceutica Remedia's quarterly Total Liabilities increased from Sep. 2025 (lei291.45 Mil) to Dec. 2025 (lei303.58 Mil) but then declined from Dec. 2025 (lei303.58 Mil) to Mar. 2026 (lei274.30 Mil).

Farmaceutica Remedia's annual Total Liabilities increased from Dec. 2023 (lei244.90 Mil) to Dec. 2024 (lei301.09 Mil) and increased from Dec. 2024 (lei301.09 Mil) to Dec. 2025 (lei303.58 Mil).

Farmaceutica Remedia Total Liabilities Historical Data

* Premium members only.

The historical data trend for Farmaceutica Remedia's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmaceutica Remedia Total Liabilities Chart

Farmaceutica Remedia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 182.85 217.77 244.90 301.09 303.58

Farmaceutica Remedia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 286.40 291.45 303.58 274.30
LTS:0M8I
58GF Score
Farmaceutica Remedia SA LTS:0M8I
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Farmaceutica Remedia Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Farmaceutica Remedia's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=298.362+(0.417+4.797
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=303.6

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=383.186-79.61
=303.6

Farmaceutica Remedia's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=269.081+(0.422+4.797
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=274.3

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=354.36-80.06
=274.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of lei274.3 Mil mean?
Farmaceutica Remedia (LTS:0M8I) has a Total Liabilities of lei274.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Farmaceutica Remedia and its competitors.
Is Farmaceutica Remedia's Total Liabilities too high?
Farmaceutica Remedia's current Total Liabilities is lei274.3 Mil. Overall, Farmaceutica Remedia has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Farmaceutica Remedia's Total Liabilities compare to MCK and CAH?
Farmaceutica Remedia's Total Liabilities of lei274.3 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Distribution company?
A good Total Liabilities depends on the Medical Distribution industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Farmaceutica Remedia and its competitors. Farmaceutica Remedia's current Total Liabilities is lei274.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmaceutica Remedia stock overvalued right now?
Farmaceutica Remedia (LTS:0M8I) has a current Total Liabilities of lei274.3 Mil. The stock's GF Value™ is lei0.23, compared to a current price of lei0.25 — trading 8.7% above its estimated fair value. The current Total Liabilities is lei274.3 Mil. Farmaceutica Remedia's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Farmaceutica Remedia (LTS:0M8I), the current Total Liabilities is lei274.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Farmaceutica Remedia (LTS:0M8I) Overvalued in 2026?

Based on GuruFocus' analysis, Farmaceutica Remedia stock appears to be overvalued. The current stock price of lei0.25 is trading 8.7% above its estimated GF Value™ of lei0.23.

Key valuation signals for LTS:0M8I:

  • Total Liabilities: lei274.3 Mil
  • GF Value™: lei0.23 vs. price of lei0.25 (8.7% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the LTS:0M8I stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Farmaceutica Remedia Business Description

Other Exchanges RMAH:Romania
Address No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
58GF Score

Get the complete analysis for LTS:0M8I

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.25
Price
lei0.23
GF Value